Opioids differentially modulate two synapses important for pain processing in the amygdala.
Pain is a subjective experience involving sensory discriminative and emotionally aversive components. Consistent with its role in pain processing and emotions, the amygdala modulates the aversive component of pain. The laterocapsular region of the central nucleus of the amygdala (CeLC) receives nociceptive information from the parabrachial nucleus (PB) and polymodal, including nociceptive, inputs from the basolateral nucleus of the amygdala (BLA). Opioids are strong analgesics and reduce both the sensory discriminative and the affective component of pain. However, it is unknown whether opioids regulate activity at the two nociceptive inputs to the amygdala. Using whole-cell electrophysiology, optogenetics and immunohistochemistry, we investigated whether opioids inhibit the rat PB-CeLC and BLA-CeLC synapse. Opioids inhibit glutamate release at the PB-CeLC and BLA-CeLC synapses. Opioid inhibition is via the μ-receptor (MOR) at the PB-CeLC synapse, whilst at the BLA-CeLC synapse, inhibition is via MOR in all neurons and via δ receptor (DOR) and κ receptor (KOR) in a subset of neurons. MOR opioids inhibit two of the synaptic inputs carrying nociceptive information into the laterocapsular amygdala. Therefore, when a person takes a MOR agonist, like morphine, it will inhibit glutamate release from PB and BLA in the CeLC and this could serve as a mechanism through which opioids reduce the affective component of pain and pain-induced associative learning. The lower than expected regulation of BLA synaptic outputs by DOR does not support the proposal that opioid receptors sub-types segregate into sub-nuclei of brain regions.